GOLDMAN SACHS GROUP INC

Position in ARGX — Argenx SE

CIK 886982 NEW YORK, NY

Back to ARGX Full portfolio

Position in ARGX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$169,407,044

+$28,795,160 QoQ

Shares Held

231,985

+38.7% QoQ

Ownership

0.373%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 88.81953574584564.ToString("F0")% Shared 0.2142379895251848.ToString("F0")% None 10.966226264629178.ToString("F0")%

Common Shares in ARGX Over Time

Shares Held

Position Value (USD)

Derivatives in ARGX

reported options exposure · as of Sep 30, 2025

CallValue

$4,130,336

CallShares

5,600

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,293,152,367 across 364 Biotechnology names. ARGX ranks #10 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,417,875	$1,079,677,898
2	REGN	Regeneron Pharmaceuticals, Inc.	1,300,558	$1,004,863,129
3	MRNA	Moderna, Inc.	6,603,697	$335,467,805
4	ROIV	Roivant Sciences Ltd.	11,111,591	$307,791,069
5	PRAX	Praxis Precision Medicines, Inc.	710,734	$228,991,385
6	INCY	Incyte Corp	2,351,221	$221,296,919
7	RVMD	Revolution Medicines, Inc.	2,185,500	$212,539,874
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,965,432	$170,933,620

All Filings in ARGX

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$169,407,044	231,985	+38.7%	Shares	Defined	2026-05-15
2025-12-31	$140,611,884	167,206	+2885.8%	Shares	Defined	2026-03-25
2025-09-30	$4,130,336	5,600	-97.1%	Call	Defined	2025-11-14
2025-09-30	$142,432,423	193,113	+3762.3%	Shares	Defined	2025-11-14
2025-06-30	$2,756,100	5,000	-96.5%	Call	Defined	2025-08-14
2025-06-30	$78,355,921	142,150	-15.8%	Shares	Defined	2025-08-14
2025-03-31	$99,886,095	168,765	+14.8%	Shares	Defined	2025-06-27
2024-12-31	$90,380,400	146,960	+11.2%	Shares	Defined	2025-02-11
2024-09-30	$71,653,217	132,182	+382.4%	Shares	Defined	2024-11-14
2024-06-30	$11,783,096	27,400	-77.7%	Put	Defined	2024-08-13
2024-06-30	$52,912,551	123,041	+1.3%	Shares	Defined	2024-08-13
2024-03-31	$47,816,506	121,448	+1114.5%	Shares	Defined	2024-05-15
2024-03-31	$3,937,200	10,000	+733.3%	Call	Defined	2024-05-15
2023-12-31	$456,516	1,200	-88.0%	Call	Defined	2024-05-14
2023-12-31	$3,804,300	10,000	-96.0%	Put	Defined	2024-05-14
2023-12-31	$96,008,737	252,369	+64.3%	Shares	Defined	2024-05-14
2023-09-30	$75,530,591	153,633	+11.6%	Shares	Defined	2024-05-15
2023-06-30	$53,663,092	137,693	-18.5%	Shares	Defined	2024-05-14
2023-03-31	$62,930,997	168,906	-11.0%	Shares	Defined	2024-05-14
2022-12-31	$71,932,240	189,880	-22.6%	Shares	Defined	2024-05-14
2022-09-30	$86,631,761	245,381	+2786.8%	Shares	Defined	2024-05-14
2022-09-30	$3,000,925	8,500	-96.9%	Call	Defined	2024-05-14
2022-06-30	$103,392,941	272,891	-18.3%	Shares	Defined	2024-05-14
2022-03-31	$105,366,826	334,169	+62.7%	Shares	Defined	2022-05-16
2021-12-31	$71,932,526	205,410	+39.7%	Shares	Defined	2022-02-17
2021-09-30	$44,415,744	147,072	+8.1%	Shares	Defined	2022-01-20
2021-06-30	$40,948,831	136,011	-5.2%	Shares	Defined	2021-08-13
2021-03-31	$39,523,972	143,520	+45.4%	Shares	Defined	2021-05-17
2020-12-31	$29,029,328	98,709	+1874.2%	Shares	Defined	2021-02-12
2020-09-30	$1,312,600	5,000	-94.6%	Put	Defined	2020-11-13
2020-09-30	$24,349,254	92,752	-24.4%	Shares	Defined	2020-11-13
2020-06-30	$27,637,747	122,709	+2354.2%	Shares	Defined	2020-08-12
2020-06-30	$1,126,150	5,000	-83.3%	Put	Defined	2020-08-12
2020-03-31	$3,951,900	30,000	+167.8%	Call	Defined	2020-05-15
2020-03-31	$1,475,639	11,202	-62.7%	Shares	Defined	2020-05-15
2020-03-31	$3,951,900	30,000	—	Put	Defined	2020-05-15
No filing history on record for this holder in this stock.